Bill Text: IL SB0010 | 2015-2016 | 99th General Assembly | Enrolled

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: Amends the Alcoholism and Other Drug Abuse and Dependency Act. In a provision concerning the Department of Human Services' Drug Overdose Prevention Program, adds State and local law enforcement agencies to the list of agencies that may apply for grants to create or support local drug overdose prevention, recognition, and response projects.

Sponsorship: Moderate Partisan Bill (Democrat 29-5)

Status: (Passed) 2016-06-30 - Public Act . . . . . . . . . 99-0519 [SB0010 Detail]

Download: Illinois-2015-SB0010-Enrolled.html

---

SB0010 Enrolled LRB099 04220 KTG 24242 b
AN ACT concerning State government.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Compassionate Use of Medical Cannabis Pilot
Program Act is amended by changing Sections 5, 10, 15, 35, 45,
60, 70, 75, and 220 and by adding Sections 7 and 57 as follows:
(410 ILCS 130/5)
(Section scheduled to be repealed on January 1, 2018)
Sec. 5. Findings.
(a) The recorded use of cannabis as a medicine goes back
nearly 5,000 years. Modern medical research has confirmed the
beneficial uses of cannabis in treating or alleviating the
pain, nausea, and other symptoms associated with a variety of
debilitating medical conditions, including cancer, multiple
sclerosis, and HIV/AIDS, as found by the National Academy of
Sciences' Institute of Medicine in March 1999.
(b) Studies published since the 1999 Institute of Medicine
report continue to show the therapeutic value of cannabis in
treating a wide array of debilitating medical conditions. These
include relief of the neuropathic pain caused by multiple
sclerosis, HIV/AIDS, and other illnesses that often fail to
respond to conventional treatments and relief of nausea,
vomiting, and other side effects of drugs used to treat

SB0010 Enrolled - 2 - LRB099 04220 KTG 24242 b
HIV/AIDS and hepatitis C, increasing the chances of patients
continuing on life-saving treatment regimens.
(c) Cannabis has many currently accepted medical uses in
the United States, having been recommended by thousands of
licensed physicians to at least 600,000 patients in states with
medical cannabis laws. The medical utility of cannabis is
recognized by a wide range of medical and public health
organizations, including the American Academy of HIV Medicine,
the American College of Physicians, the American Nurses
Association, the American Public Health Association, the
Leukemia & Lymphoma Society, and many others.
(d) Data from the Federal Bureau of Investigation's Uniform
Crime Reports and the Compendium of Federal Justice Statistics
show that approximately 99 out of every 100 cannabis arrests in
the U.S. are made under state law, rather than under federal
law. Consequently, changing State law will have the practical
effect of protecting from arrest the vast majority of seriously
ill patients who have a medical need to use cannabis.
(d-5) In 2014, the Task Force on Veterans' Suicide was
created by the Illinois General Assembly to gather data on
veterans' suicide prevention. Data from a U.S. Department of
Veterans Affairs study indicates that 22 veterans commit
suicide each day.
(e) Alaska, Arizona, California, Colorado, Connecticut,
Delaware, Hawaii, Maine, Massachusetts, Michigan, Montana,
Nevada, New Jersey, New Mexico, Oregon, Rhode Island, Vermont,

SB0010 Enrolled - 3 - LRB099 04220 KTG 24242 b
Washington, and Washington, D.C. have removed state-level
criminal penalties from the medical use and cultivation of
cannabis. Illinois joins in this effort for the health and
welfare of its citizens.
(f) States are not required to enforce federal law or
prosecute people for engaging in activities prohibited by
federal law. Therefore, compliance with this Act does not put
the State of Illinois in violation of federal law.
(g) State law should make a distinction between the medical
and non-medical uses of cannabis. Hence, the purpose of this
Act is to protect patients with debilitating medical
conditions, as well as their physicians and providers, from
arrest and prosecution, criminal and other penalties, and
property forfeiture if the patients engage in the medical use
of cannabis.
(Source: P.A. 98-122, eff. 1-1-14.)
(410 ILCS 130/7 new)
Sec. 7. Lawful user and lawful products. For the purposes
of this Act and to clarify the legislative findings on the
lawful use of cannabis:
(1) A cardholder under this Act shall not be considered
an unlawful user or addicted to narcotics solely as a
result of his or her qualifying patient or designated
caregiver status.
(2) All medical cannabis products purchased by a

SB0010 Enrolled - 4 - LRB099 04220 KTG 24242 b
qualifying patient at a licensed dispensing organization
shall be lawful products and a distinction shall be made
between medical and non-medical uses of cannabis as a
result of the qualifying patient's cardholder status under
the authorized use granted under State law.
(410 ILCS 130/10)
(Section scheduled to be repealed on January 1, 2018)
Sec. 10. Definitions. The following terms, as used in this
Act, shall have the meanings set forth in this Section:
(a) "Adequate supply" means:
(1) 2.5 ounces of usable cannabis during a period of 14
days and that is derived solely from an intrastate source.
(2) Subject to the rules of the Department of Public
Health, a patient may apply for a waiver where a physician
provides a substantial medical basis in a signed, written
statement asserting that, based on the patient's medical
history, in the physician's professional judgment, 2.5
ounces is an insufficient adequate supply for a 14-day
period to properly alleviate the patient's debilitating
medical condition or symptoms associated with the
debilitating medical condition.
(3) This subsection may not be construed to authorize
the possession of more than 2.5 ounces at any time without
authority from the Department of Public Health.
(4) The pre-mixed weight of medical cannabis used in

SB0010 Enrolled - 5 - LRB099 04220 KTG 24242 b
making a cannabis infused product shall apply toward the
limit on the total amount of medical cannabis a registered
qualifying patient may possess at any one time.
(b) "Cannabis" has the meaning given that term in Section 3
of the Cannabis Control Act.
(c) "Cannabis plant monitoring system" means a system that
includes, but is not limited to, testing and data collection
established and maintained by the registered cultivation
center and available to the Department for the purposes of
documenting each cannabis plant and for monitoring plant
development throughout the life cycle of a cannabis plant
cultivated for the intended use by a qualifying patient from
seed planting to final packaging.
(d) "Cardholder" means a qualifying patient or a designated
caregiver who has been issued and possesses a valid registry
identification card by the Department of Public Health.
(e) "Cultivation center" means a facility operated by an
organization or business that is registered by the Department
of Agriculture to perform necessary activities to provide only
registered medical cannabis dispensing organizations with
usable medical cannabis.
(f) "Cultivation center agent" means a principal officer,
board member, employee, or agent of a registered cultivation
center who is 21 years of age or older and has not been
convicted of an excluded offense.
(g) "Cultivation center agent identification card" means a

SB0010 Enrolled - 6 - LRB099 04220 KTG 24242 b
document issued by the Department of Agriculture that
identifies a person as a cultivation center agent.
(h) "Debilitating medical condition" means one or more of
the following:
(1) cancer, glaucoma, positive status for human
immunodeficiency virus, acquired immune deficiency
syndrome, hepatitis C, amyotrophic lateral sclerosis,
Crohn's disease, agitation of Alzheimer's disease,
cachexia/wasting syndrome, muscular dystrophy, severe
fibromyalgia, spinal cord disease, including but not
limited to arachnoiditis, Tarlov cysts, hydromyelia,
syringomyelia, Rheumatoid arthritis, fibrous dysplasia,
spinal cord injury, traumatic brain injury and
post-concussion syndrome, Multiple Sclerosis,
Arnold-Chiari malformation and Syringomyelia,
Spinocerebellar Ataxia (SCA), Parkinson's, Tourette's,
Myoclonus, Dystonia, Reflex Sympathetic Dystrophy, RSD
(Complex Regional Pain Syndromes Type I), Causalgia, CRPS
(Complex Regional Pain Syndromes Type II),
Neurofibromatosis, Chronic Inflammatory Demyelinating
Polyneuropathy, Sjogren's syndrome, Lupus, Interstitial
Cystitis, Myasthenia Gravis, Hydrocephalus, nail-patella
syndrome, residual limb pain, seizures (including those
characteristic of epilepsy), post-traumatic stress
disorder (PTSD), or the treatment of these conditions; or
(1.5) terminal illness with a diagnosis of 6 months or

SB0010 Enrolled - 7 - LRB099 04220 KTG 24242 b
less; if the terminal illness is not one of the qualifying
debilitating medical conditions, then the physician shall
on the certification form identify the cause of the
terminal illness; or
(2) any other debilitating medical condition or its
treatment that is added by the Department of Public Health
by rule as provided in Section 45.
(i) "Designated caregiver" means a person who: (1) is at
least 21 years of age; (2) has agreed to assist with a
patient's medical use of cannabis; (3) has not been convicted
of an excluded offense; and (4) assists no more than one
registered qualifying patient with his or her medical use of
cannabis.
(j) "Dispensing organization agent identification card"
means a document issued by the Department of Financial and
Professional Regulation that identifies a person as a medical
cannabis dispensing organization agent.
(k) "Enclosed, locked facility" means a room, greenhouse,
building, or other enclosed area equipped with locks or other
security devices that permit access only by a cultivation
center's agents or a dispensing organization's agent working
for the registered cultivation center or the registered
dispensing organization to cultivate, store, and distribute
cannabis for registered qualifying patients.
(l) "Excluded offense" for cultivation center agents and
dispensing organizations means:

SB0010 Enrolled - 8 - LRB099 04220 KTG 24242 b
(1) a violent crime defined in Section 3 of the Rights
of Crime Victims and Witnesses Act or a substantially
similar offense that was classified as a felony in the
jurisdiction where the person was convicted; or
(2) a violation of a state or federal controlled
substance law, the Cannabis Control Act, or the
Methamphetamine Control and Community Protection Act that
was classified as a felony in the jurisdiction where the
person was convicted, except that the registering
Department may waive this restriction if the person
demonstrates to the registering Department's satisfaction
that his or her conviction was for the possession,
cultivation, transfer, or delivery of a reasonable amount
of cannabis intended for medical use. This exception does
not apply if the conviction was under state law and
involved a violation of an existing medical cannabis law.
For purposes of this subsection, the Department of Public
Health shall determine by emergency rule within 30 days after
the effective date of this amendatory Act of the 99th General
Assembly what constitutes a "reasonable amount".
(l-5) "Excluded offense" for a qualifying patient or
designated caregiver means a violation of state or federal
controlled substance law, the Cannabis Control Act, or the
Methamphetamine and Community Protection Act that was
classified as a felony in the jurisdiction where the person was
convicted, except that the registering Department may waive

SB0010 Enrolled - 9 - LRB099 04220 KTG 24242 b
this restriction if the person demonstrates to the registering
Department's satisfaction that his or her conviction was for
the possession, cultivation, transfer, or delivery of a
reasonable amount of cannabis intended for medical use. This
exception does not apply if the conviction was under state law
and involved a violation of an existing medical cannabis law.
For purposes of this subsection, the Department of Public
Health shall determine by emergency rule within 30 days after
the effective date of this amendatory Act of the 99th General
Assembly what constitutes a "reasonable amount".
(m) "Medical cannabis cultivation center registration"
means a registration issued by the Department of Agriculture.
(n) "Medical cannabis container" means a sealed,
traceable, food compliant, tamper resistant, tamper evident
container, or package used for the purpose of containment of
medical cannabis from a cultivation center to a dispensing
organization.
(o) "Medical cannabis dispensing organization", or
"dispensing organization", or "dispensary organization" means
a facility operated by an organization or business that is
registered by the Department of Financial and Professional
Regulation to acquire medical cannabis from a registered
cultivation center for the purpose of dispensing cannabis,
paraphernalia, or related supplies and educational materials
to registered qualifying patients.
(p) "Medical cannabis dispensing organization agent" or

SB0010 Enrolled - 10 - LRB099 04220 KTG 24242 b
"dispensing organization agent" means a principal officer,
board member, employee, or agent of a registered medical
cannabis dispensing organization who is 21 years of age or
older and has not been convicted of an excluded offense.
(q) "Medical cannabis infused product" means food, oils,
ointments, or other products containing usable cannabis that
are not smoked.
(r) "Medical use" means the acquisition; administration;
delivery; possession; transfer; transportation; or use of
cannabis to treat or alleviate a registered qualifying
patient's debilitating medical condition or symptoms
associated with the patient's debilitating medical condition.
(s) "Physician" means a doctor of medicine or doctor of
osteopathy licensed under the Medical Practice Act of 1987 to
practice medicine and who has a controlled substances license
under Article III of the Illinois Controlled Substances Act. It
does not include a licensed practitioner under any other Act
including but not limited to the Illinois Dental Practice Act.
(t) "Qualifying patient" means a person who has been
diagnosed by a physician as having a debilitating medical
condition.
(u) "Registered" means licensed, permitted, or otherwise
certified by the Department of Agriculture, Department of
Public Health, or Department of Financial and Professional
Regulation.
(v) "Registry identification card" means a document issued

SB0010 Enrolled - 11 - LRB099 04220 KTG 24242 b
by the Department of Public Health that identifies a person as
a registered qualifying patient or registered designated
caregiver.
(w) "Usable cannabis" means the seeds, leaves, buds, and
flowers of the cannabis plant and any mixture or preparation
thereof, but does not include the stalks, and roots of the
plant. It does not include the weight of any non-cannabis
ingredients combined with cannabis, such as ingredients added
to prepare a topical administration, food, or drink.
(x) "Verification system" means a Web-based system
established and maintained by the Department of Public Health
that is available to the Department of Agriculture, the
Department of Financial and Professional Regulation, law
enforcement personnel, and registered medical cannabis
dispensing organization agents on a 24-hour basis for the
verification of registry identification cards, the tracking of
delivery of medical cannabis to medical cannabis dispensing
organizations, and the tracking of the date of sale, amount,
and price of medical cannabis purchased by a registered
qualifying patient.
(y) "Written certification" means a document dated and
signed by a physician, stating (1) that in the physician's
professional opinion the patient is likely to receive
therapeutic or palliative benefit from the medical use of
cannabis to treat or alleviate the patient's debilitating
medical condition or symptoms associated with the debilitating

SB0010 Enrolled - 12 - LRB099 04220 KTG 24242 b
medical condition; (2) that the qualifying patient has a
debilitating medical condition and specifying the debilitating
medical condition the qualifying patient has; and (2) (3) that
the patient is under the physician's care for the physician is
treating or managing treatment of the patient's debilitating
medical condition. A written certification shall be made only
in the course of a bona fide physician-patient relationship,
after the physician has completed an assessment of the
qualifying patient's medical history, reviewed relevant
records related to the patient's debilitating condition, and
conducted a physical examination.
A veteran who has received treatment at a VA hospital shall
be deemed to have a bona fide physician-patient relationship
with a VA physician if the patient has been seen for his or her
debilitating medical condition at the VA Hospital in accordance
with VA Hospital protocols.
A bona fide physician-patient relationship under this
subsection is a privileged communication within the meaning of
Section 8-802 of the Code of Civil Procedure.
(Source: P.A. 98-122, eff. 1-1-14; 98-775, eff. 1-1-15.)
(410 ILCS 130/15)
(Section scheduled to be repealed on January 1, 2018)
Sec. 15. Authority.
(a) It is the duty of the Department of Public Health to
enforce the following provisions of this Act unless otherwise

SB0010 Enrolled - 13 - LRB099 04220 KTG 24242 b
provided for by this Act:
(1) establish and maintain a confidential registry of
qualifying patients authorized to engage in the medical use
of cannabis and their caregivers;
(2) distribute educational materials about the health
benefits and risks associated with the use abuse of
cannabis and prescription medications;
(3) adopt rules to administer the patient and caregiver
registration program; and
(4) adopt rules establishing food handling
requirements for cannabis-infused products that are
prepared for human consumption.
(b) It is the duty of the Department of Agriculture to
enforce the provisions of this Act relating to the registration
and oversight of cultivation centers unless otherwise provided
for in this Act.
(c) It is the duty of the Department of Financial and
Professional Regulation to enforce the provisions of this Act
relating to the registration and oversight of dispensing
organizations unless otherwise provided for in this Act.
(d) The Department of Public Health, the Department of
Agriculture, or the Department of Financial and Professional
Regulation shall enter into intergovernmental agreements, as
necessary, to carry out the provisions of this Act including,
but not limited to, the provisions relating to the registration
and oversight of cultivation centers, dispensing

SB0010 Enrolled - 14 - LRB099 04220 KTG 24242 b
organizations, and qualifying patients and caregivers.
(e) The Department of Public Health, Department of
Agriculture, or the Department of Financial and Professional
Regulation may suspend, revoke, or impose other penalties upon
a registration for violations of this Act and any rules adopted
in accordance thereto. The suspension or revocation of, or
imposition of any other penalty upon, a registration is a final
Agency action, subject to judicial review. Jurisdiction and
venue for judicial review are vested in the Circuit Court.
(Source: P.A. 98-122, eff. 1-1-14; 98-1172, eff. 1-12-15.)
(410 ILCS 130/35)
(Section scheduled to be repealed on January 1, 2018)
Sec. 35. Physician requirements.
(a) A physician who certifies a debilitating medical
condition for a qualifying patient shall comply with all of the
following requirements:
(1) The Physician shall be currently licensed under the
Medical Practice Act of 1987 to practice medicine in all
its branches and in good standing, and must hold a
controlled substances license under Article III of the
Illinois Controlled Substances Act.
(2) A physician certifying a patient's condition
making a medical cannabis recommendation shall comply with
generally accepted standards of medical practice, the
provisions of the Medical Practice Act of 1987 and all

SB0010 Enrolled - 15 - LRB099 04220 KTG 24242 b
applicable rules.
(3) The physical examination required by this Act may
not be performed by remote means, including telemedicine.
(4) The physician shall maintain a record-keeping
system for all patients for whom the physician has
certified the patient's medical condition recommended the
medical use of cannabis. These records shall be accessible
to and subject to review by the Department of Public Health
and the Department of Financial and Professional
Regulation upon request.
(b) A physician may not:
(1) accept, solicit, or offer any form of remuneration
from or to a qualifying patient, primary caregiver,
cultivation center, or dispensing organization, including
each principal officer, board member, agent, and employee,
to certify a patient, other than accepting payment from a
patient for the fee associated with the required
examination;
(2) offer a discount of any other item of value to a
qualifying patient who uses or agrees to use a particular
primary caregiver or dispensing organization to obtain
medical cannabis;
(3) conduct a personal physical examination of a
patient for purposes of diagnosing a debilitating medical
condition at a location where medical cannabis is sold or
distributed or at the address of a principal officer,

SB0010 Enrolled - 16 - LRB099 04220 KTG 24242 b
agent, or employee or a medical cannabis organization;
(4) hold a direct or indirect economic interest in a
cultivation center or dispensing organization if he or she
recommends the use of medical cannabis to qualified
patients or is in a partnership or other fee or
profit-sharing relationship with a physician who
recommends medical cannabis, except for the limited
purpose of performing a medical cannabis related research
study;
(5) serve on the board of directors or as an employee
of a cultivation center or dispensing organization;
(6) refer patients to a cultivation center, a
dispensing organization, or a registered designated
caregiver; or
(7) advertise in a cultivation center or a dispensing
organization.
(c) The Department of Public Health may with reasonable
cause refer a physician, who has certified a debilitating
medical condition of a patient, to the Illinois Department of
Financial and Professional Regulation for potential violations
of this Section.
(d) Any violation of this Section or any other provision of
this Act or rules adopted under this Act is a violation of the
Medical Practice Act of 1987.
(Source: P.A. 98-122, eff. 1-1-14; 98-1172, eff. 1-12-15.)

SB0010 Enrolled - 17 - LRB099 04220 KTG 24242 b
(410 ILCS 130/45)
(Section scheduled to be repealed on January 1, 2018)
Sec. 45. Addition of debilitating medical conditions.
(a) Any resident citizen may petition the Department of
Public Health to add debilitating conditions or treatments to
the list of debilitating medical conditions listed in
subsection (h) of Section 10. The Department of Public Health
shall consider petitions in the manner required by Department
rule, including public notice and hearing. The Department shall
approve or deny a petition within 180 days of its submission,
and, upon approval, shall proceed to add that condition by rule
in accordance with the Administrative Procedure Act. The
approval or denial of any petition is a final decision of the
Department, subject to judicial review. Jurisdiction and venue
are vested in the Circuit Court.
(b) The Department shall accept petitions once annually for
a one-month period determined by the Department. During the
open period, the Department shall accept petitions from any
resident requesting the addition of a new debilitating medical
condition or disease to the list of approved debilitating
medical conditions for which the use of cannabis has been shown
to have a therapeutic or palliative effect. The Department
shall provide public notice 30 days before the open period for
accepting petitions, which shall describe the time period for
submission, the required format of the submission, and the
submission address.

SB0010 Enrolled - 18 - LRB099 04220 KTG 24242 b
(c) Each petition shall be limited to one proposed
debilitating medical condition or disease.
(d) A petitioner shall file one original petition in the
format provided by the Department and in the manner specified
by the Department. For a petition to be processed and reviewed,
the following information shall be included:
(1) The petition, prepared on forms provided by the
Department, in the manner specified by the Department.
(2) A specific description of the medical condition or
disease that is the subject of the petition. Each petition
shall be limited to a single condition or disease.
Information about the proposed condition or disease shall
include:
(A) the extent to which the condition or disease
itself or the treatments cause severe suffering, such
as severe or chronic pain, severe nausea or vomiting,
or otherwise severely impair a person's ability to
conduct activities of daily living;
(B) information about why conventional medical
therapies are not sufficient to alleviate the
suffering caused by the disease or condition and its
treatment;
(C) the proposed benefits from the medical use of
cannabis specific to the medical condition or disease;
(D) evidence from the medical community and other
experts supporting the use of medical cannabis to

SB0010 Enrolled - 19 - LRB099 04220 KTG 24242 b
alleviate suffering caused by the condition, disease,
or treatment;
(E) letters of support from physicians or other
licensed health care providers knowledgeable about the
condition or disease, including, if feasible, a letter
from a physician with whom the petitioner has a bona
fide physician-patient relationship;
(F) any additional medical, testimonial, or
scientific documentation; and
(G) an electronic copy of all materials submitted.
(3) Upon receipt of a petition, the Department shall:
(A) determine whether the petition meets the
standards for submission and, if so, shall accept the
petition for further review; or
(B) determine whether the petition does not meet
the standards for submission and, if so, shall deny the
petition without further review.
(4) If the petition does not fulfill the standards for
submission, the petition shall be considered deficient.
The Department shall notify the petitioner, who may correct
any deficiencies and resubmit the petition during the next
open period.
(e) The petitioner may withdraw his or her petition by
submitting a written statement to the Department indicating
withdrawal.
(f) Upon review of accepted petitions, the Director shall

SB0010 Enrolled - 20 - LRB099 04220 KTG 24242 b
render a final decision regarding the acceptance or denial of
the proposed debilitating medical conditions or diseases.
(g) The Department shall convene a Medical Cannabis
Advisory Board (Advisory Board) composed of 16 members, which
shall include:
(1) one medical cannabis patient advocate or
designated caregiver;
(2) one parent or designated caregiver of a person
under the age of 18 who is a qualified medical cannabis
patient;
(3) two registered nurses or nurse practitioners;
(4) three registered qualifying patients, including
one veteran; and
(5) nine health care practitioners with current
professional licensure in their field. The Advisory Board
shall be composed of health care practitioners
representing the following areas:
(A) neurology;
(B) pain management;
(C) medical oncology;
(D) psychiatry or mental health;
(E) infectious disease;
(F) family medicine;
(G) general primary care;
(H) medical ethics;
(I) pharmacy;

SB0010 Enrolled - 21 - LRB099 04220 KTG 24242 b
(J) pediatrics; or
(K) psychiatry or mental health for children or
adolescents.
At least one appointed health care practitioner shall have
direct experience related to the health care needs of veterans
and at least one individual shall have pediatric experience.
(h) Members of the Advisory Board shall be appointed by the
Governor.
(1) Members shall serve a term of 4 years or until a
successor is appointed and qualified. If a vacancy occurs,
the Governor shall appoint a replacement to complete the
original term created by the vacancy.
(2) The Governor shall select a chairperson.
(3) Members may serve multiple terms.
(4) Members shall not have an affiliation with, serve
on the board of, or have a business relationship with a
registered cultivation center or a registered medical
cannabis dispensary.
(5) Members shall disclose any real or apparent
conflicts of interest that may have a direct bearing of the
subject matter, such as relationships with pharmaceutical
companies, biomedical device manufacturers, or
corporations whose products or services are related to the
medical condition or disease to be reviewed.
(6) Members shall not be paid but shall be reimbursed
for travel expenses incurred while fulfilling the

SB0010 Enrolled - 22 - LRB099 04220 KTG 24242 b
responsibilities of the Advisory Board.
(i) On the effective date of this amendatory Act of the
99th General Assembly, the terms of office of the members of
the Advisory Board serving on that effective date shall
terminate and the Board shall be reconstituted.
(j) The Advisory Board shall convene at the call of the
Chair:
(1) to examine debilitating conditions or diseases
that would benefit from the medical use of cannabis; and
(2) to review new medical and scientific evidence
pertaining to currently approved conditions.
(k) The Advisory Board shall issue an annual report of its
activities each year.
(l) The Advisory Board shall receive administrative
support from the Department.
(Source: P.A. 98-122, eff. 1-1-14; revised 10-21-15.)
(410 ILCS 130/57 new)
Sec. 57. Qualifying patients under 18. Qualifying patients
that are under the age of 18 years shall not be prohibited from
having 2 designated caregivers as follows: if both biological
parents or 2 legal guardians of a qualifying patient under 18
both have significant decision-making responsibilities over
the qualifying patient, then both may serve as a designated
caregiver if they otherwise meet the definition of "designated
caregiver" under Section 10; however, if only one biological

SB0010 Enrolled - 23 - LRB099 04220 KTG 24242 b
parent or legal guardian has significant decision-making
responsibilities for the qualifying patient under 18, then he
or she may appoint a second designated caregiver who meets the
definition of "designated caregiver" under Section 10.
(410 ILCS 130/60)
(Section scheduled to be repealed on January 1, 2018)
Sec. 60. Issuance of registry identification cards.
(a) Except as provided in subsection (b), the Department of
Public Health shall:
(1) verify the information contained in an application
or renewal for a registry identification card submitted
under this Act, and approve or deny an application or
renewal, within 30 days of receiving a completed
application or renewal application and all supporting
documentation specified in Section 55;
(2) issue registry identification cards to a
qualifying patient and his or her designated caregiver, if
any, within 15 business days of approving the application
or renewal;
(3) enter the registry identification number of the
registered dispensing organization the patient designates
into the verification system; and
(4) allow for an electronic application process, and
provide a confirmation by electronic or other methods that
an application has been submitted.

SB0010 Enrolled - 24 - LRB099 04220 KTG 24242 b
(b) The Department of Public Health may not issue a
registry identification card to a qualifying patient who is
under 18 years of age, unless that patient suffers from
seizures, including those characteristic of epilepsy, or as
provided by administrative rule. The Department of Public
Health shall adopt rules for the issuance of a registry
identification card for qualifying patients who are under 18
years of age and suffering from seizures, including those
characteristic of epilepsy. The Department of Public Health may
adopt rules to allow other individuals under 18 years of age to
become registered qualifying patients under this Act with the
consent of a parent or legal guardian. Registered qualifying
patients under 18 years of age shall be prohibited from
consuming forms of cannabis other than medical cannabis infused
products and purchasing any usable cannabis.
(c) A veteran who has received treatment at a VA hospital
is deemed to have a bona fide physician-patient relationship
with a VA physician if the patient has been seen for his or her
debilitating medical condition at the VA hospital in accordance
with VA hospital protocols. All reasonable inferences
regarding the existence of a bona fide physician-patient
relationship shall be drawn in favor of an applicant who is a
veteran and has undergone treatment at a VA hospital.
(c-10) An individual who submits an application as someone
who is terminally ill shall have all fees and fingerprinting
requirements waived. The Department of Public Health shall

SB0010 Enrolled - 25 - LRB099 04220 KTG 24242 b
within 30 days after this amendatory Act of the 99th General
Assembly adopt emergency rules to expedite approval for
terminally ill individuals. These rules shall include, but not
be limited to, rules that provide that applications by
individuals with terminal illnesses shall be approved or denied
within 14 days of their submission.
(d) Upon the approval of the registration and issuance of a
registry card under this Section, the Department of Public
Health shall forward the designated caregiver or registered
qualified patient's driver's registration number to the
Secretary of State and certify that the individual is permitted
to engage in the medical use of cannabis. For the purposes of
law enforcement, the Secretary of State shall make a notation
on the person's driving record stating the person is a
registered qualifying patient who is entitled to the lawful
medical use of cannabis. If the person no longer holds a valid
registry card, the Department shall notify the Secretary of
State and the Secretary of State shall remove the notation from
the person's driving record. The Department and the Secretary
of State may establish a system by which the information may be
shared electronically.
(e) Upon the approval of the registration and issuance of a
registry card under this Section, the Department of Public
Health shall electronically forward the registered qualifying
patient's identification card information to the Prescription
Monitoring Program established under the Illinois Controlled

SB0010 Enrolled - 26 - LRB099 04220 KTG 24242 b
Substances Act and certify that the individual is permitted to
engage in the medical use of cannabis. For the purposes of
patient care, the Prescription Monitoring Program shall make a
notation on the person's prescription record stating that the
person is a registered qualifying patient who is entitled to
the lawful medical use of cannabis. If the person no longer
holds a valid registry card, the Department of Public Health
shall notify the Prescription Monitoring Program and
Department of Human Services to remove the notation from the
person's record. The Department of Human Services and the
Prescription Monitoring Program shall establish a system by
which the information may be shared electronically. This
confidential list may not be combined or linked in any manner
with any other list or database except as provided in this
Section.
(f) All applicants for a registry card shall be
fingerprinted as part of the application process if they are a
first-time applicant, if their registry card has already
expired, or if they previously have had their registry card
revoked or otherwise denied. At renewal, cardholders whose
registry cards have not yet expired, been revoked, or otherwise
denied shall not be subject to fingerprinting. Registry cards
shall be revoked by the Department of Public Health if the
Department of Public Health is notified by the Secretary of
State that a cardholder has been convicted of an excluded
offense. For purposes of enforcing this subsection, the

SB0010 Enrolled - 27 - LRB099 04220 KTG 24242 b
Department of Public Health and Secretary of State shall
establish a system by which violations reported to the
Secretary of State under paragraph 18 of subsection (a) of
Section 6-205 of the Illinois Vehicle Code shall be shared with
the Department of Public Health.
(Source: P.A. 98-122, eff. 1-1-14; 98-775, eff. 1-1-15.)
(410 ILCS 130/70)
(Section scheduled to be repealed on January 1, 2018)
Sec. 70. Registry identification cards.
(a) A registered qualifying patient or designated
caregiver must keep their registry identification card in his
or her possession at all times when engaging in the medical use
of cannabis.
(b) Registry identification cards shall contain the
following:
(1) the name of the cardholder;
(2) a designation of whether the cardholder is a
designated caregiver or qualifying patient;
(3) the date of issuance and expiration date of the
registry identification card;
(4) a random alphanumeric identification number that
is unique to the cardholder;
(5) if the cardholder is a designated caregiver, the
random alphanumeric identification number of the
registered qualifying patient the designated caregiver is

SB0010 Enrolled - 28 - LRB099 04220 KTG 24242 b
receiving the registry identification card to assist; and
(6) a photograph of the cardholder, if required by
Department of Public Health rules.
(c) To maintain a valid registration identification card, a
registered qualifying patient and caregiver must annually
resubmit, at least 45 days prior to the expiration date stated
on the registry identification card, a completed renewal
application, renewal fee, and accompanying documentation as
described in Department of Public Health rules. The Department
of Public Health shall send a notification to a registered
qualifying patient or registered designated caregiver 90 days
prior to the expiration of the registered qualifying patient's
or registered designated caregiver's identification card. If
the Department of Public Health fails to grant or deny a
renewal application received in accordance with this Section,
then the renewal is deemed granted and the registered
qualifying patient or registered designated caregiver may
continue to use the expired identification card until the
Department of Public Health denies the renewal or issues a new
identification card.
(d) Except as otherwise provided in this Section, the
expiration date is 3 years one year after the date of issuance.
(e) The Department of Public Health may electronically
store in the card any or all of the information listed in
subsection (b), along with the address and date of birth of the
cardholder and the qualifying patient's designated dispensary

SB0010 Enrolled - 29 - LRB099 04220 KTG 24242 b
organization, to allow it to be read by law enforcement agents.
(Source: P.A. 98-122, eff. 1-1-14.)
(410 ILCS 130/75)
(Section scheduled to be repealed on January 1, 2018)
Sec. 75. Notifications to Department of Public Health and
responses; civil penalty.
(a) The following notifications and Department of Public
Health responses are required:
(1) A registered qualifying patient shall notify the
Department of Public Health of any change in his or her
name or address, or if the registered qualifying patient
ceases to have his or her debilitating medical condition,
within 10 days of the change.
(2) A registered designated caregiver shall notify the
Department of Public Health of any change in his or her
name or address, or if the designated caregiver becomes
aware the registered qualifying patient passed away,
within 10 days of the change.
(3) Before a registered qualifying patient changes his
or her designated caregiver, the qualifying patient must
notify the Department of Public Health.
(4) If a cardholder loses his or her registry
identification card, he or she shall notify the Department
within 10 days of becoming aware the card has been lost.
(b) When a cardholder notifies the Department of Public

SB0010 Enrolled - 30 - LRB099 04220 KTG 24242 b
Health of items listed in subsection (a), but remains eligible
under this Act, the Department of Public Health shall issue the
cardholder a new registry identification card with a new random
alphanumeric identification number within 15 business days of
receiving the updated information and a fee as specified in
Department of Public Health rules. If the person notifying the
Department of Public Health is a registered qualifying patient,
the Department shall also issue his or her registered
designated caregiver, if any, a new registry identification
card within 15 business days of receiving the updated
information.
(c) If a registered qualifying patient ceases to be a
registered qualifying patient or changes his or her registered
designated caregiver, the Department of Public Health shall
promptly notify the designated caregiver. The registered
designated caregiver's protections under this Act as to that
qualifying patient shall expire 15 days after notification by
the Department.
(d) A cardholder who fails to make a notification to the
Department of Public Health that is required by this Section is
subject to a civil infraction, punishable by a penalty of no
more than $150.
(e) A registered qualifying patient shall notify the
Department of Public Health of any change to his or her
designated registered dispensing organization. Registered
dispensing organizations must comply with all requirements of

SB0010 Enrolled - 31 - LRB099 04220 KTG 24242 b
this Act.
(f) If the registered qualifying patient's certifying
physician notifies the Department in writing that either the
registered qualifying patient has ceased to suffer from a
debilitating medical condition or that the physician no longer
believes the patient would receive therapeutic or palliative
benefit from the medical use of cannabis, the card shall become
null and void. However, the registered qualifying patient shall
have 15 days to destroy his or her remaining medical cannabis
and related paraphernalia.
(Source: P.A. 98-122, eff. 1-1-14.)
(410 ILCS 130/220)
(Section scheduled to be repealed on January 1, 2018)
Sec. 220. Repeal of Act. This Act is repealed on July 1,
2020 4 years after the effective date of this Act.
(Source: P.A. 98-122, eff. 1-1-14.)
Section 99. Effective date. This Act takes effect upon
becoming law.